Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02849470Phase 1Withdrawn

AGA Biocellular Stem/Stromal Hair Regenerative Study

Role: collaborator

NCT04886414Not ApplicableCompleted

Home-based Care and Hand Hygiene Interventions in Honduras

Role: collaborator

NCT03510273Not ApplicableCompleted

Honduras Liger Thermocoagulator Study

Role: collaborator

NCT00207532Not ApplicableCompleted

Dosage Effects of Folic Acid on Blood Folates of Honduran Women

Role: collaborator

All 4 trials loaded